Truxima
These highlights do not include all the information needed to use TRUXIMA safely and effectively. See full prescribing information for TRUXIMA.TRUXIMA® (rituximab-abbs) injection, for intravenous useInitial U.S. Approval: 2018TRUXIMA (rituximab-abbs) is biosimilar* to RITUXAN® (rituximab).
9af3ddc7-4217-417a-ac89-8704edc5bc44
HUMAN PRESCRIPTION DRUG LABEL
Nov 20, 2023
Cephalon, Inc.
DUNS: 183236314
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
rituximab-abbs
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
rituximab-abbs
Product Details
FDA regulatory identification and product classification information